From theGlobe and Mail:
Ottawa considers changing patent rules
The federal government has proposed amending the country's drug patent regulations to eliminate the drug industry's ability to delay generic competition with pre-emptive lawsuits.
Known as evergreening, the practice now allows drug manufacturers, which already have 20-year patent protection, to trigger further 24-month extensions, making it difficult for generic firms to produce cheaper copies of brand-name drugs.
Wednesday, December 15, 2004
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment